Les Newsletters de Stop-Tabac.ch

Webmasters - Proposez nos news sur votre site

Rechercher dans les anciennes newsletter:

13 mars 2012

La newsletter de stop-tabac: les sujets clés de l?actualité mondiale sur le tabagisme

Sélection réalisée par Jean-François Etter

Le 13 mars 2012


- Sevrage tabagique: mieux que les statines
- Lien vers stop-tabac svp
- The tobacco industry is terrified of plain packs
- Chattez avec un médecin tabacologue


Sevrage tabagique: mieux que les statines

Statines enfoncées par le sevrage Une étude sur 19 000 patients vient de comparer chez les coronariens l'efficacité de fortes doses de statine au sevrage tabagique. Les critères retenus étaient les événements majeurs qui peuvent survenir chez le coronarien : décès d'origine cardiaque, infarctus du myocarde, accident vasculaire cérébral ou arrêt cardiaque ressuscité. Les fumeurs ont un risque d'événements majeurs augmenté de 70 % par rapport à celui des non fumeurs. Si on compare ce risque à celui des anciens fumeurs, il est augmenté de 60 %. Les chercheurs ont analysé les résultats en fonction des traitements utilisant les statines. Le sevrage tabagique apporte un bénéfice à 5 ans deux fois supérieur à celui obtenu avec les fortes doses de statine.

NDRL : les statines sont remboursées, les traitements du sevrage ne le sont toujours pas malgré leur nécessité et leur efficacité.

Frey P et al Impact of smoking on cardiovascular events in patients with coronary disease receiving contemporary medical therapy (from the Treating to New Targets [TNT] and the Incremental Decrease in End Points Through Aggressive Lipid Lowering [IDEAL] trials), Am J Cardiol 2011

Source: Lettre Tabac & Liberté

http://www.tabac-liberte.com/m_articles.asp?id=750 (09 03 2012)
(13 03 2012)


Lien vers stop-tabac svp

Mettez svp un lien vers Stop-Tabac.ch sur votre site web ou votre blog ou page Facebook ou Twitter ou sur des forums de discussion. Pour le code à insérer dans votre page web, voir sur la page:

divers/creer-un-lien-vers-stop-tabac.html (10 08 2011)
(13 03 2012)


The tobacco industry is terrified of plain packs

Snowdon's report on plain packaging for the Adam Smith Institute is clearly a mélange of spurious rubbish.1 But is it spurious rubbish funded by big tobacco? Snowdon's website once had a (now removed) notice saying he was not tobacco industry funded (http://twitpic.com/8mqgbw). The report says nothing about its funding. However, when questioned about the independence of his report on Radio 4's Today programme on 20 February, Snowdon acknowledged that the Adam Smith Institute receives less than 3% of its turnover from tobacco companies and extended this invitation to listeners: If you want to disregard the report's finding on that basis then go ahead.

He argues that plain packs will make counterfeiting easier, on the assumption that plain packs will be dull cardboard boxes. In fact, they will have full colour graphic warnings and be no easier to forge than current packs, which as one Hong Kong counterfeiter told an Australian TV reporter are 100% easy to counterfeit (http://t.co/5xHUzSgW). If prices fall, governments can increase tobacco tax and force retail prices up, as they regularly do now.

On page 6 Snowdon writes: Plain packaging . . . neither informs nor educates. On the contrary, it limits information. But on page 12: Cigarette packs do not provide information, they do not make claims, and they do not seek to persuade. Please make up your mind, Mr Snowdon.

The accuracy of Snowdon's research might be judged by this. He writes that I co-founded BUGA UP, the Australian antitobacco graffiti group. This is news to me and all who were in BUGA UP. I co-founded a group called MOP UP.2 And Snowdon calls himself an historian.

The tobacco industry is terrified of plain packs. Its frenzied global actions to challenge plain packaging via courts, tribunals, and reports like this speak volumes about what it fears it will do to its deadly business. Bring it on.

Simon Chapman, BMJ 2012;344:e1617

http://www.bmj.com/content/344/bmj.e1617 (07 03 2012)
(13 03 2012)



Retour à la liste des newsletters